| 000 | 00992 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516144014.0 | ||
| 264 | 0 | _c20130826 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1499-2752 | ||
| 024 | 7 |
_a10.3899/jrheum.121413 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeBlanc, Claire M A | |
| 245 | 0 | 0 |
_aDr. LeBlanc, et al reply. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cMar 2013 |
||
| 300 |
_a339 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xdrug therapy |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Services Accessibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aLang, Bianca | |
| 700 | 1 | _aTucker, Lori B | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 40 _gno. 3 _gp. 339 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.121413 _zAvailable from publisher's website |
| 999 |
_c22661114 _d22661114 |
||